Key risks
- ₹123.31 Cr loss in March 2021 reversed ₹18.66 Cr profit in March 2020; extent and drivers of deterioration require clarification.
- No revenue reported across recent quarters (marked n/a), obscuring operational activity, project execution status, and recovery trajectory.
- Stock declined 16.54% over 12 months despite low leverage (D/E 0.47), indicating sustained market skepticism about recovery timeline.
- Verify the causes of the March 2021 loss (asset write-down, contract losses, project delays) and management's timeframe for cash-positive operations.
Generated analysis · source review pending